Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises)

doi:10.4291/wjgp.v13.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4571)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

219

WORD

189

HTML

1832

Figures (1-5)

204

Tables (1-1)

189

Sum=2633

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

257

Download

515

Sum=772

Publishing Process of This Article

Item

Count

Browse

428

Download

738

Sum=1166

Jan 22, 2022 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Gastrointest Pathophysiol. Jan 22, 2022; 13(1): 1-14
Published online Jan 22, 2022. doi: 10.4291/wjgp.v13.i1.1

Full Size Figure Download Figure

Figure 5 Role of molecular docking from drug discovery to clinical use.

Citation: El-Nakeep S. Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises). World J Gastrointest Pathophysiol 2022; 13(1): 1-14
URL: https://www.wjgnet.com/2150-5330/full/v13/i1/1.htm
DOI: https://dx.doi.org/10.4291/wjgp.v13.i1.1